RaQualia Pharma Inc. (TYO:4579)
Japan · Delayed Price · Currency is JPY 574.00
-1.00 (-0.17%)
Aug 27, 2026, 11:29 AM JST
RaQualia Pharma Market Cap
RaQualia Pharma has a market cap or net worth of 14.97 billion as of August 26, 2026. Its market cap has increased by 11.48% in one year.
Market Cap
14.97B
Enterprise Value
12.96B
Revenue
3.90B
Ranking
n/a
PE Ratio
90.90
Stock Price
574.00
ChartMarket Cap Chart
Since July 20, 2011, RaQualia Pharma's market cap has decreased from 19.90B to 14.97B, a decrease of -24.79%. That is a compound annual growth rate of -1.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 14.97B | -39.41% |
| Dec 30, 2025 | 24.70B | 194.57% |
| Dec 30, 2024 | 8.39B | -43.62% |
| Dec 29, 2023 | 14.87B | -42.44% |
| Dec 30, 2022 | 25.84B | 5.05% |
| Dec 30, 2021 | 24.60B | 17.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 22.38B |
| Renascience | 17.94B |
| AnGes | 15.55B |
| CanBas | 15.33B |
| ReproCELL | 14.69B |
| Stella Pharma | 12.50B |
| Kubota Pharmaceutical Holdings | 11.03B |
| Immuno-Biological Laboratories | 10.06B |